-+ 0.00%
-+ 0.00%
-+ 0.00%

Silo Pharma Enters Asset Purchase Agreement With Parkview Consulting On August 18, 2026; Issues 165,000 Shares As Consideration For Asset Purchase

Benzinga·08/19/2026 21:21:43
Listen to the news

-SEC Filing